Search for: "U.S. v. Zabel" Results 21 - 35 of 35
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Jan 2012, 3:30 pm by Benjamin Wittes
Need for Comparisons between Reformed Military Commissions and U.S. [read post]
5 Oct 2018, 5:52 am
Securities and Exchange Commission, on Saturday, September 29, 2018 Tags: Capital markets, Cryptocurrency, Derivatives, Disclosure, Engagement, Exchange-traded funds, Human capital, Investment advisers, Oversight, Retail investors, SEC, US House The SEC and Foreign Private Issuers: A Path to Optimal Public Enforcement Posted by Yuliya Guseva (Rutgers), on Sunday, September 30, 2018 Tags: Compliance and disclosure… [read post]
27 Jan 2017, 6:08 am
Simon, Schulte Roth & Zabel LLP, on Wednesday, January 25, 2017 Tags: Acquisition agreements, Acquisitions, Appraisal rights, Boards of Directors, Break fees, Covenants, Deal protection, Delaware law, DGCL, Fiduciary outs, Merger litigation, Mergers & acquisitions, Target firms, Tender offer White Collar and Regulatory Enforcement: What to Expect in 2017 Posted by John F. [read post]
30 Mar 2018, 6:01 am
Financial Crisis Inquiry Commission (2009-2011), on Tuesday, March 27, 2018 Tags: Banks, Deregulation, Dodd-Frank Act, Financial crisis, Financial Crisis Inquiry Commission, Financial institutions, Financial regulation, Foreign banks, Leverage, Prudence, S. 2155, Systemic risk, Too big to fail, US Senate Upcoming Volcker Rule Regulatory Changes Posted by Mark V. [read post]
5 Mar 2012, 3:32 pm by Caleb Mason
  The client says that in 1991 he had not yet left the D.R. and had never been to the U.S. [read post]
3 Apr 2012, 1:00 pm by Benjamin Wittes
Earlier today, I had the pleasure of visiting Professor Jack Goldsmith’s “Foreign Relations Law” class, which is studying Hamdan v. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]